Fig. 1From: Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July–November 2021Adjusted vaccine effectiveness against infection (red), hospitalisation (blue), ICU admission (yellow) and COVID-19 associated deaths (orange) for Norwegian adults using data from 15 July to 30 November 2021. Adjusted for age, sex, comorbidities, county of residence, country of birth, and living conditionsBack to article page